Anti-TNFs’ Link To Cancer In Children Under Investigation By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency is investigating approximately 30 reports of cancer in pediatric patients.
You may also be interested in...
FDA Warns Again Of Rare Cancer Associated With TNF Blockers
FDA is asking for an additional round of label changes for the tumor necrosis factor inhibitor class, as a consequence of mounting evidence of cases of a rare and usually fatal type of lymphoma in patients taking the drugs.
FDA Warns Again Of Rare Cancer Associated With TNF Blockers
FDA is asking for an additional round of label changes for the tumor necrosis factor inhibitor class, as a consequence of mounting evidence of cases of a rare and usually fatal type of lymphoma in patients taking the drugs.
TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry
The only elevated cancer type in patients taking the biologic drugs was non-melanoma skin cancer, investigator reports at rheumatology scientific conference.